These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
639 related items for PubMed ID: 23137515
1. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells. Nakou M, Papadimitraki ED, Fanouriakis A, Bertsias GK, Choulaki C, Goulidaki N, Sidiropoulos P, Boumpas DT. Clin Exp Rheumatol; 2013; 31(2):172-9. PubMed ID: 23137515 [Abstract] [Full Text] [Related]
2. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Papadimitraki ED, Choulaki C, Koutala E, Bertsias G, Tsatsanis C, Gergianaki I, Raptopoulou A, Kritikos HD, Mamalaki C, Sidiropoulos P, Boumpas DT. Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805 [Abstract] [Full Text] [Related]
3. Decreased expression of interleukin-21 receptor on peripheral B lymphocytes in systemic lupus erythematosus. Mitoma H, Horiuchi T, Kimoto Y, Tsukamoto H, Uchino A, Tamimoto Y, Miyagi Y, Harada M. Int J Mol Med; 2005 Oct; 16(4):609-15. PubMed ID: 16142394 [Abstract] [Full Text] [Related]
4. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus. Cai Z, Wong CK, Kam NW, Dong J, Jiao D, Chu M, Lam CW, Tam LS. Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926 [Abstract] [Full Text] [Related]
5. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus. Luo J, Niu X, Liu H, Zhang M, Chen M, Deng S. Mol Immunol; 2013 Dec; 56(4):574-82. PubMed ID: 23911415 [Abstract] [Full Text] [Related]
6. Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production. Zhang X, Lindwall E, Gauthier C, Lyman J, Spencer N, Alarakhia A, Fraser A, Ing S, Chen M, Webb-Detiege T, Zakem J, Davis W, Choi YS, Quinet R. Lupus; 2015 Aug; 24(9):909-17. PubMed ID: 25654980 [Abstract] [Full Text] [Related]
7. Peripheral CD24hi CD27+ CD19+ B cells subset as a potential biomarker in naïve systemic lupus erythematosus. Jin L, Weiqian C, Lihuan Y. Int J Rheum Dis; 2013 Dec; 16(6):698-708. PubMed ID: 24286662 [Abstract] [Full Text] [Related]
8. Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity. Wong CK, Wong PT, Tam LS, Li EK, Chen DP, Lam CW. J Clin Immunol; 2010 Jan; 30(1):45-52. PubMed ID: 19774453 [Abstract] [Full Text] [Related]
9. Increased interleukin 21 and follicular helper T-like cells and reduced interleukin 10+ B cells in patients with new-onset systemic lupus erythematosus. Wang L, Zhao P, Ma L, Shan Y, Jiang Z, Wang J, Jiang Y. J Rheumatol; 2014 Sep; 41(9):1781-92. PubMed ID: 25028374 [Abstract] [Full Text] [Related]
10. IVIg attenuates TLR-9 activation in B cells from SLE patients. Kessel A, Peri R, Haj T, Snir A, Slobodin G, Sabo E, Rosner I, Shoenfeld Y, Toubi E. J Clin Immunol; 2011 Feb; 31(1):30-8. PubMed ID: 20922561 [Abstract] [Full Text] [Related]
11. Physiological up-regulation of inhibitory receptors Fc gamma RII and CR1 on memory B cells is lacking in SLE patients. Isaák A, Gergely P, Szekeres Z, Prechl J, Poór G, Erdei A, Gergely J. Int Immunol; 2008 Feb; 20(2):185-92. PubMed ID: 18182380 [Abstract] [Full Text] [Related]
12. [Effect of serum interleukin-21 on B cell secretory capacity and apoptosis in patients with systemic lupus erythematosus]. Zheng LT, Zhao LD, Zhao C, Zhao Y, Zhang X, Zhang FC, Zeng XF, Tang FL, You X. Zhonghua Nei Ke Za Zhi; 2017 Feb 01; 56(2):116-120. PubMed ID: 28162181 [Abstract] [Full Text] [Related]
13. Increased frequency of a unique spleen tyrosine kinase bright memory B cell population in systemic lupus erythematosus. Fleischer SJ, Giesecke C, Mei HE, Lipsky PE, Daridon C, Dörner T. Arthritis Rheumatol; 2014 Dec 01; 66(12):3424-35. PubMed ID: 25156507 [Abstract] [Full Text] [Related]
14. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus. Nakano S, Morimoto S, Suzuki J, Nozawa K, Amano H, Tokano Y, Takasaki Y. Rheumatology (Oxford); 2008 Feb 01; 47(2):145-9. PubMed ID: 18160420 [Abstract] [Full Text] [Related]
15. Characterization of 5C11-positive activated interferon-producing cells in patients with systemic lupus erythematosus. Ohshima M, Kanda H, Kubo K, Yonezumi-Hayashi A, Tateishi S, Yamamoto K. Lupus; 2013 Jan 01; 22(1):44-51. PubMed ID: 23087259 [Abstract] [Full Text] [Related]
17. Increased Tim-3 expression on peripheral T lymphocyte subsets and association with higher disease activity in systemic lupus erythematosus. Song LJ, Wang X, Wang XP, Li D, Ding F, Liu HX, Yu X, Li XF, Shu Q. Diagn Pathol; 2015 Jun 16; 10():71. PubMed ID: 26076826 [Abstract] [Full Text] [Related]
18. Increased Syk phosphorylation leads to overexpression of TRAF6 in peripheral B cells of patients with systemic lupus erythematosus. Iwata S, Yamaoka K, Niiro H, Jabbarzadeh-Tabrizi S, Wang SP, Kondo M, Yoshikawa M, Akashi K, Tanaka Y. Lupus; 2015 Jun 16; 24(7):695-704. PubMed ID: 25432781 [Abstract] [Full Text] [Related]
19. Evaluation of TLR9 expression on PBMCs and CpG ODN-TLR9 ligation on IFN-α production in SLE patients. Mortezagholi S, Babaloo Z, Rahimzadeh P, Namdari H, Ghaedi M, Gharibdoost F, Mirzaei R, Bidad K, Salehi E. Immunopharmacol Immunotoxicol; 2017 Feb 16; 39(1):11-18. PubMed ID: 28049380 [Abstract] [Full Text] [Related]
20. Perturbations of peripheral B lymphocyte homoeostasis in children with systemic lupus erythematosus. Odendahl M, Keitzer R, Wahn U, Hiepe F, Radbruch A, Dörner T, Bunikowski R. Ann Rheum Dis; 2003 Sep 16; 62(9):851-8. PubMed ID: 12922958 [Abstract] [Full Text] [Related] Page: [Next] [New Search]